Literature DB >> 16356122

Diabetic vascular disease: it's all the RAGE.

Barry I Hudson1, Thoralf Wendt, Loredana G Bucciarelli, Ling Ling Rong, Yoshifumi Naka, Shi Fang Yan, Ann Marie Schmidt.   

Abstract

The major consequence of long-term diabetes is the increased incidence of disease of the vasculature. Of the underlying mechanisms leading to disease, the accumulation of advanced glycation end products (AGEs), resulting from the associated hyperglycemia, is the most convincing. Interaction of AGEs with their receptor, RAGE, activates numerous signaling pathways leading to activation of proinflammatory and procoagulatory genes. Studies in rodent models of macro- and microvascular disease have demonstrated that blockade of RAGE can prevent development of disease. These observations highlight RAGE as a therapeutic target for treatment of diabetic vascular disease. Antioxid. Redox Signal. 7, 1588-1600.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356122     DOI: 10.1089/ars.2005.7.1588

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  14 in total

1.  Is there any association between GLY82 ser polymorphism of rage gene and Turkish diabetic and non diabetic patients with coronary artery disease?

Authors:  Ozlem Kucukhuseyin; Hulya Yilmaz-Aydogan; C Selim Isbir; Turgay Isbir
Journal:  Mol Biol Rep       Date:  2011-09-25       Impact factor: 2.316

2.  Association between the receptor for advanced glycation end products gene polymorphisms and coronary artery disease.

Authors:  Lan Liu; Xing-biao Qiu
Journal:  Mol Biol Rep       Date:  2013-11       Impact factor: 2.316

3.  Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases.

Authors:  Lih-Fen Lue; Douglas Gordon Walker; Sandra Jacobson; Marwan Sabbagh
Journal:  Future Neurol       Date:  2009

4.  High-mobility group box proteins modulate tumor necrosis factor-alpha expression in osteoclastogenesis via a novel deoxyribonucleic acid sequence.

Authors:  Kosj Yamoah; Alina Brebene; Ramkumarie Baliram; Kenji Inagaki; Georgia Dolios; Ario Arabi; Rinosha Majeed; Hitoshi Amano; Rong Wang; Robert Yanagisawa; Etsuko Abe
Journal:  Mol Endocrinol       Date:  2008-01-24

5.  Reasons to Investigate the Soluble Receptor for Advanced Glycation End-Product (sRAGE) Pathway in Aortic Disease.

Authors:  Abdullah Sarkar; Kailash Prasad; Bulat A Ziganshin; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2013-08-01

6.  Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene.

Authors:  Anastasia Z Kalea; Nina Reiniger; Hojin Yang; Maria Arriero; Ann Marie Schmidt; Barry I Hudson
Journal:  FASEB J       Date:  2009-01-22       Impact factor: 5.191

Review 7.  Soluble forms of RAGE in internal medicine.

Authors:  Natale Vazzana; Francesca Santilli; Chiara Cuccurullo; Giovanni Davì
Journal:  Intern Emerg Med       Date:  2009-09-02       Impact factor: 3.397

8.  Hypoglycemic effect of resveratrol in type 2 diabetic model db/db mice and its actions in cultured L6 myotubes and RIN-5F pancreatic β-cells.

Authors:  Miki Minakawa; Atutoshi Kawano; Yutaka Miura; Kazumi Yagasaki
Journal:  J Clin Biochem Nutr       Date:  2011-04-13       Impact factor: 3.114

9.  Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease.

Authors:  L Arab; R Sadeghi; D G Walker; L-F Lue; M N Sabbagh
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

10.  Medical bioremediation of age-related diseases.

Authors:  Jacques M Mathieu; John Schloendorn; Bruce E Rittmann; Pedro Jj Alvarez
Journal:  Microb Cell Fact       Date:  2009-04-09       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.